: Failure to effectively control pain remains a challenge in sickle cell disease (SCD)
patients. This cross-sectional study in 106 Zimbabwean SCD patients demonstrated the role of UGT2B7
polymorphism in SCD patient pain management. #AiBST #pharmacogenetics #sickle cell disease
